Posted inGenetics
New Antibiotic, Manikomycin, Acts on Novel Ribosomal Target
Ribosome [JUAN GAERTNER / Science Photo Library / Getty Images] Traditionally, antibiotic discovery has involved the isolation of natural products…
Posted inBiotechnology
Easy One-Step Aqueous Synthesis of Fused Azole–Pyrimidine Heat-Resistant Energetic Materials
In the rapidly evolving realm of energetic materials, the quest for compounds that seamlessly integrate high thermal stability, potent detonation…
Posted inBiotechnology
Biotech value creation at an inflection point
Sponsored By Lumanity Jun 8, 2026 8:00am Innovation in life sciences has never been more exciting, but the bar for…
Posted inBiotechnology
Mining Sparks Widespread Deforestation in Africa
In a groundbreaking study published recently, the extent of mining-induced deforestation in sub-Saharan Africa has been revealed to be vastly…
Posted inBiotechnology
Why AI is changing clinical development
Artificial intelligence is quickly becoming a competitive advantage in clinical development. In this interview, PhaseV CEO and co-founder Raviv Pryluk…
Posted inBiotechnology
Critiquing the Proposed 2-Year Neonatal Fellowship Pathway
In the rapidly evolving landscape of neonatal-perinatal medicine, an intense debate has emerged surrounding a recent proposal by the American…
Posted inBiotechnology
How AI is reshaping biopharma decision-making
Artificial intelligence is rapidly transforming the life sciences landscape, but according to Henry Levy, president of life sciences and health…
Posted inGenetics
NIIMBL to Support Vector Production and AI-Ready Training Projects
Viral vector production and training schemes designed to foster development of an AI-ready workforce dominate the list of projects selected…
Posted inGenetics
Web App Helps Flag Antibodies Where Manufacturability Might Be an Issue
Researchers have developed an open-source web app to help drug manufacturers and developers identify unstable antibodies prone to aggregation. The…
Posted inGenetics
Gentler Cell Separation Methods Gain Momentum
The race to commercialize cell therapies is forcing bioprocessing innovators to confront one of the field’s most persistent manufacturing bottlenecks:…